- Home
- IPA
as 12-18-2024 4:00pm EST
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, Australia and others. The majority of its revenue is derived from United States of America.
| Founded: | 1983 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 18.9M | IPO Year: | 2017 |
| Target Price: | $5.00 | AVG Volume (30 days): | 297.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.74 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.33 - $2.60 | Next Earning Date: | 12-10-2024 |
| Revenue: | $17,272,336 | Revenue Growth: | 6.36% |
| Revenue Growth (this year): | 1.88% | Revenue Growth (next year): | 9.90% |
Latest ImmunoPrecise Antibodies Ltd. News
IPA Breaking Stock News: Dive into IPA Ticker-Specific Updates for Smart Investing
Simply Wall St.
8 days ago
ImmunoPrecise Antibodies Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Business Wire
8 days ago
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025
Business Wire
14 days ago
IPA to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
Business Wire
15 days ago
IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 on December 10, 2024
ACCESSWIRE
22 days ago
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025
Business Wire
a month ago
$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies
Business Wire
a month ago
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation
Business Wire
2 months ago
ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology
Compare IPA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IPA ImmunoPrecise Antibodies Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.